Voting Results along with the Scrutinizers Report of the 36th AGM of the Company held on 27th September 2025 through VC/OAVM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals Ltd held its 36th Annual General Meeting on September 27, 2025 at 10:00 AM via video conferencing. All five resolutions were passed with overwhelming majority, with over 99.99% of votes cast in favour of each resolution. The resolutions included adoption of audited financial statements for FY ending March 31, 2025, re-appointment of Mr. Dasi Reddy Rakesh as a director, regularization of two additional independent directors (Mrs. Dakshita Jain and Mrs. P. Meena Kumari), and approval to increase the authorised share capital with a corresponding amendment to the Memorandum of Association. Total valid votes polled were approximately 14.16 lakh across all resolutions, with negligible votes against.
This is a routine AGM compliance filing with no surprises — all resolutions sailed through easily. The proposed increase in authorised share capital is the most material item for shareholders, as it signals potential future fundraising or stock issuance, though no immediate dilution has been announced.